GITR: A Modulator of Immune Response and Inflammation-Reference-Cited by-同舟云学术

GITR: A Modulator of Immune Response and Inflammation

Published:2009 Issue: Volume: Page:156-173
ISSN:0065-2598
Container-title:Advances in Experimental Medicine and Biology
language:
Short-container-title:

Author:

Nocentini Giuseppe,Riccardi Carlo

Publisher

Springer New York

Link

http://link.springer.com/content/pdf/10.1007/978-0-387-89520-8_11.pdf

Reference80 articles.

1. Sakaguchi S, Sakaguchi N, Asano M et al. Immunologic self-tolerance maintained by activated T-cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155(3):1151–1164.

2. Beissert S, Schwarz A, Schwarz T. Regulatory T-cells. J Invest Dermatol 2006; 126(1):15–24.

3. Watts TH. TNF/TNFR family members in costimulation of T-cell responses. Annu Rev Immunol 2005; 23:23–68.

4. Nocentini G, Giunchi L, Ronchetti S et al. A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T-cell receptor-induced apoptosis. Proc Natl Acad Sci USA 1997; 94(12):6216–6221.

5. Bossen C, Ingold K, Tardivel A et al. Interactions of Tumor Necrosis Factor (TNF) and TNF Receptor Family Members in the Mouse and Human. J Biol Chem 2006; 281(20):13964–14971.

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Methylated Cyclodextrin KLEPTOSE® CRYSMEB on Inflammatory Responses in Human In Vitro Models;International Journal of Molecular Sciences;2024-09-09

2. CD163+ macrophages in mantle cell lymphoma induce activation of prosurvival pathways and immune suppression;Blood Advances;2024-08-16

3. TIGIT expression on neoplastic cells is a poor prognostic factor for adult T-cell leukaemia/lymphoma;Pathology;2024-08

4. Exploring the Role of GITR/GITRL Signaling: From Liver Disease to Hepatocellular Carcinoma;Cancers;2024-07-22

5. Integrated transcriptomic and immunological profiling reveals new diagnostic and prognostic models for cutaneous melanoma;Frontiers in Pharmacology;2024-05-28